Lyell Immunopharma (LYEL) Asset Utilization Ratio (2021 - 2025)
Lyell Immunopharma (LYEL) has disclosed Asset Utilization Ratio for 5 consecutive years, with 0.0 as the latest value for Q4 2025.
- Quarterly Asset Utilization Ratio fell 12.42% to 0.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.0 through Dec 2025, down 12.42% year-over-year, with the annual reading at 0.0 for FY2025, 11.86% down from the prior year.
- Asset Utilization Ratio hit 0.0 in Q4 2025 for Lyell Immunopharma, down from 0.0 in the prior quarter.
- In the past five years, Asset Utilization Ratio ranged from a high of 0.09 in Q1 2023 to a low of 0.0 in Q2 2024.
- Historically, Asset Utilization Ratio has averaged 0.02 across 5 years, with a median of 0.0 in 2022.
- Biggest five-year swings in Asset Utilization Ratio: surged 1063.08% in 2023 and later tumbled 99.9% in 2024.
- Year by year, Asset Utilization Ratio stood at 0.01 in 2021, then soared by 865.78% to 0.09 in 2022, then plummeted by 99.81% to 0.0 in 2023, then plummeted by 34.69% to 0.0 in 2024, then decreased by 12.42% to 0.0 in 2025.
- Business Quant data shows Asset Utilization Ratio for LYEL at 0.0 in Q4 2025, 0.0 in Q3 2025, and 0.0 in Q2 2025.